NEW YORK (GenomeWeb News) – French molecular diagnostics company Genomic Vision today announced the launch of its initial public offering.

It plans to offer about 1.3 million shares of its stock at an expected price range of between €13.5 ($18.61) and €16.5 per share. At the midpoint of the range, the IPO is anticipated to raise about €20 million ($27.6 million), Genomic Vision said. The company plans to list its shares on Euronext Paris.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.